Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Patients and Prescriber Perceptions of Cell and Gene Therapy (CGT) in Oncology

NCT03336567 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03336567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Patients and Prescriber Perceptions of Cell and Gene Therapy (CGT) in Oncology
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
December 4, 2017
Completion date
June 12, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms